Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

Science News About Schizophrenia

Professional looking young woman standing in a conference room while smiling and holding a tablet, with a group of people working in the background.
RAISE-ing the Standard of Care for Schizophrenia: The Rapid Adoption of Coordinated Specialty Care in the United States

75th Anniversary

The Recovery After an Initial Schizophrenia Episode research initiative, launched by NIMH to test the effectiveness of coordinated specialty care to treat first-episode psychosis, has transformed the mental health landscape in the United States and helped thousands of people with schizophrenia achieve better outcomes.

DNA strand beside a side profile of a head with the brain illuminated, on an abstract digital background
Researchers Map the Genetic Landscape of Schizophrenia in the Brain

In a comprehensive postmortem genetic analysis of the caudate nucleus in the brain, NIMH-supported researchers identified many genes associated with schizophrenia risk, including a gene that regulates the flow of the chemical messenger dopamine.

Abstract image of program code being analyzed
Computational Methods Identify Psychosis Symptoms in Spoken Language

Researchers used computational methods to automatically detect abnormalities in spoken language that could be used to predict symptoms of psychotic disorders including schizophrenia.

A doctor wearing a white lab coat and stethoscope facing a male patient wearing a white and blue flannel shirt.
Clinical Decision Support System Reduces Cardiovascular Risk in Patients With Serious Mental Illness

A new study shows the use of a clinical decision support system to prompt the use of shared decision-making tools, such as handouts, may result in positive impacts on long-term cardiovascular health in patients with serious mental illness.

Illustration of DNA double helix
Gene Readouts Contribute To Distinctness of Mental Disorders

A new study conducted by researchers at NIMH suggests that differences in the expression of gene transcripts – readouts copied from DNA that help maintain and build our cells – may hold the key to understanding how mental disorders with shared genetic risk factors result in different patterns of onset, symptoms, course of illness, and treatment responses.

Adolescents taking a selfie
NIH Initiative Expands Access to Resources for Early Psychosis Treatment and Research

The Early Psychosis Intervention Network (EPINET), an NIMH initiative aimed at determining how to best provide treatment for individuals experiencing symptoms of early psychosis, is increasing access to resources for researchers, providers, and families through a growing network of research hubs and a new website.

outline art of male and female human figures
NIMH Part of Collaborative Effort to Advance Early Intervention for Individuals at Risk of Developing Schizophrenia

NIMH has joined with other NIH Institutes in launching an new Accelerating Medicines Partnership focused on advancing the development of better ways to identify and treat those at clinical high risk for psychosis.

Neuronal spines
Schizophrenia Risk Gene Linked to Cognitive Deficits in Mice

Mice with an impaired version of one the few genes definitively linked to schizophrenia showed abnormalities in working memory, mimicking those commonly seen in schizophrenia patients.

microscopic image of an induced human neuron
Gene Regulators Work Together for Oversized Impact on Schizophrenia Risk

Gene expression regulators work together to raise an individual’s risk of developing schizophrenia. Schizophrenia-like gene expression changes modeled in human neurons matched changes found in patients’ brains.

a group of young people sits on grass in the sun
NIH Announces Funding Awards for National Early Psychosis Learning Community

NIMH awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.

ALACRITY - Progress, Promising Practices, and Future Prospects - Center Directors' Meeting - July 16-17, 1029, Bethesda, MD
Mental Health Research Centers Forge Collaborations – with ALACRITY

Mental health research center directors emerged from a recent meeting with a renewed commitment to help each other achieve their common mission – to transform care of children, adolescents and adults with severe psychiatric disorders.

MRI image displays a map of substantia nigra voxels where NM-MRI signal was positively correlated with severity of psychotic symptoms.
Neuromelanin-Sensitive MRI Identified as a Potential Biomarker for Psychosis

Researchers have shown that a type of magnetic resonance imaging — called neuromelanin-sensitive MRI (NM-MRI) — is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness.

A heatmap shows the amount of time a mouse spent in locations of an open field chamber during optogenetic stimulation of the cerebellar input to the VTA.
New Findings Reveal Surprising Role of the Cerebellum in Reward and Social Behaviors

A new study in rodents has demonstrated, for the first time, that the brain’s cerebellum plays a role in controlling reward and social preference behavior—findings that shed light on the brain circuits critical to the affective and social dysfunction seen across multiple psychiatric disorders.